Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles

被引:152
作者
Hu, F. X. [1 ]
Neoh, K. G. [1 ]
Kang, E. T. [1 ]
机构
[1] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore
关键词
composite nanoparticles; magnetic drug targeting; controlled release; tamoxifen; MRI;
D O I
10.1016/j.biomaterials.2006.07.014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The present study deals with the synthesis and characterization of tamoxifen-loaded magnetite/poly(L-lactic acid) composite nanoparticles (TMCN), and their in vitro anti-cancer activity against MCF-7 breast cancer cells. The composite nanoparticles with an average size of similar to 200nm, were synthesized via a solvent evaporation/extraction technique in an oil/water emulsion. The superparamagnetic property (saturation magnetization value of similar to 7emu/g) of the TMCN is provided by Fe3O4 nanoparticles of similar to 6nm encapsulated in the poly(L-lactic acid) matrix. The encapsulation efficiency of the Fe3O4 and tamoxifen as a function of the concentration in the organic phase was investigated. The uptake of TMCN and tamoxifen by MCF-7 was estimated from the intracellular iron concentration. After 4h incubation of MCF-7 with TMCN, significant changes in the cell morphology were discernible from phase contrast microscopy. Cytotoxicity assay shows that while the Fe3O4-loaded poly(L-lactic acid) composite nanoparticles exhibit no significant cytotoxicity against MCF-7, similar to 80% of the these cells were killed after incubation for 4 days with TMCN. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5725 / 5733
页数:9
相关论文
共 45 条
[1]   Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment [J].
Alexiou, C ;
Jurgons, R ;
Schmid, RJ ;
Bergemann, C ;
Henke, J ;
Erhardt, W ;
Huenges, E ;
Parak, F .
JOURNAL OF DRUG TARGETING, 2003, 11 (03) :139-149
[2]   Synthesis and characterization of poly (ethyl-2-cyanoacrylate) nanoparticles with a magnetic core [J].
Arias, JL ;
Gallardo, V ;
Gómez-Lopera, SA ;
Plaza, RC ;
Delgado, AV .
JOURNAL OF CONTROLLED RELEASE, 2001, 77 (03) :309-321
[3]   Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields [J].
Asmatulu, R ;
Zalich, MA ;
Claus, RO ;
Riffle, JS .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 292 :108-119
[4]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[5]   Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression [J].
Cameron, DA ;
Ritchie, AA ;
Langdon, S ;
Anderson, TJ ;
Miller, WR .
BREAST CANCER RESEARCH AND TREATMENT, 1997, 45 (02) :99-107
[6]   Tamoxifen-loaded polymeric micelles: Preparation, physico-chemical characterization and in vitro evaluation studies [J].
Cavallaro, G ;
Maniscalco, L ;
Licciardi, M ;
Giammona, G .
MACROMOLECULAR BIOSCIENCE, 2004, 4 (11) :1028-1038
[7]  
Chawla JS, 2003, AAPS PHARMSCI, V5
[8]   Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen [J].
Chawla, JS ;
Amiji, MM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :127-138
[9]   Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery [J].
Choi, H ;
Choi, SR ;
Zhou, R ;
Kung, HF ;
Chen, IW .
ACADEMIC RADIOLOGY, 2004, 11 (09) :996-1004
[10]  
Clarke M, 1998, LANCET, V351, P1451